A critical review of randomized and smaller lithium trials in Alzheimer’s disease examines prior positive signals, mixed results, and unanswered questions.
Key Takeaways
- More Media Appearances Peter has had the honor of appearing as a guest on many podcasts
- More Disclosures It is very important to Peter
- This trial also measured lithium’s effect on the molecular damage that is the hallmark of AD